STRYKER CORP Income (Loss) from Continuing Operations, Per Diluted Share
STRYKER CORP (SYK) reported Income (Loss) from Continuing Operations, Per Diluted Share of $2.77 per share for the 12-month period ending 2009-12-31, per its 10-K filed 2010-02-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2010-02-26
- STRYKER CORP income (loss) from continuing operations, per diluted share for fiscal 2009 was $2.77, a 0.36% decline from fiscal 2008.
- STRYKER CORP income (loss) from continuing operations, per diluted share for fiscal 2008 was $2.78, a 17.30% increase from fiscal 2007.
- STRYKER CORP income (loss) from continuing operations, per diluted share for fiscal 2007 was $2.37.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 12 month |
|---|---|
| 2009-12-31 | $2.77 10-K · filed 2010-02-26 |
| 2008-12-31 | $2.78 10-K · filed 2010-02-26 |
| 2007-12-31 | $2.37 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |